Mon, August 5, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 8, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 3, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 10, 2023
[ 12:00 AM ] - WOPRAI
Mon, May 8, 2023
[ 12:00 AM ] - WOPRAI
Thu, February 16, 2023
[ 12:00 AM ] - WOPRAI
Mon, February 6, 2023
[ 12:00 AM ] - WOPRAI
Wed, February 1, 2023
[ 12:00 AM ] - WOPRAI
Wed, November 2, 2022
[ 12:00 AM ] - WOPRAI
Tue, November 1, 2022
[ 12:00 AM ] - WOPRAI
Wed, August 17, 2022
[ 12:00 AM ] - WOPRAI
Wed, August 3, 2022
[ 12:00 AM ] - WOPRAI
Wed, May 25, 2022
[ 12:00 AM ] - WOPRAI
Wed, August 18, 2021
[ 12:00 AM ] - WOPRAI
Wed, August 4, 2021
[ 12:00 AM ] - WOPRAI
Wed, June 23, 2021
[ 12:00 AM ] - WOPRAI
Wed, May 26, 2021
[ 12:00 AM ] - WOPRAI
Wed, February 17, 2021
Catherine Ramsey Maintained (TWST) at Buy with Increased Target to $46 on, Aug 5th, 2024
Catherine Ramsey of Baird, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Increased Target from $40 to $46 on, Aug 5th, 2024.
Catherine has made no other calls on TWST in the last 4 months.
There are 5 other peers that have a rating on TWST. Out of the 5 peers that are also analyzing TWST, 0 agree with Catherine's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Catherine
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $55 on, Tuesday, July 9th, 2024
- Steven Mah of "TD Cowen" Maintained at Strong Buy with Increased Target to $65 on, Thursday, June 13th, 2024
- Subbu Nambi of "Guggenheim" Initiated at Strong Buy and Held Target at $53 on, Wednesday, June 5th, 2024
- Sung Ji Nam of "Scotiabank" Maintained at Buy with Increased Target to $48 on, Monday, May 6th, 2024
- Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Increased Target to $50 on, Friday, May 3rd, 2024
Contributing Sources